Quantcast
Last updated on April 20, 2014 at 19:30 EDT

Latest Percutaneous coronary intervention Stories

2013-07-18 08:29:30

More Mature Markets in Western Europe Will See Marginal Declines, According to Millennium Research Group TORONTO, July 18, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, markets for interventional cardiology (IC) devices have reached maturation in Belgium, Sweden, Switzerland and the Netherlands, while Eastern European markets will continue to see growth. Procedure volume growth will be slight in...

2013-07-17 12:26:53

Deployment of HeartWays at Van Dyk Montclair and investment in advanced cardiac nurse practitioner emphasize commitment to specialized post-acute care and reducing unnecessary hospital readmissions MONTCLAIR, N.J., July 17, 2013 /PRNewswire/ -- Van Dyk Health Care, Inc. announces the deployment of its HeartWays cardiac rehab program at its Van Dyk Montclair facility, along with hiring Nicole Cofini, RN, cardiac nurse practitioner to oversee the program. Cofini comes to Van Dyk Health...

2013-07-12 08:23:50

Device Facilitates Delivery of Interventional Devices in Complex PCI Procedures NATICK, Mass., July 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration 510(k) clearance and CE Mark approval for the Guidezilla(TM) Guide Extension Catheter and has launched the device in the U.S. and Europe. The Guidezilla device is designed to make complex percutaneous coronary intervention (PCI) procedures easier by more efficiently...

2013-07-11 08:26:01

Rising Use of Less Invasive Treatments Will Lead to Declines in Procedure Volumes, According to Millennium Research Group TORONTO, July 11, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, declines in isolated coronary artery bypass graft (CABG) procedures in the United States and Europe will primarily be attributed to the increasing use of percutaneous coronary intervention (PCI), which is less...

2013-07-10 10:21:08

Emmanouil S. Brilakis, M.D., Ph.D., of the VA North Texas Health Care System and University of Texas Southwestern Medical Center at Dallas, and colleagues conducted a review of medical literature regarding optimal medical therapy after percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries). The researchers identified 91 studies for inclusion in the review. "Percutaneous coronary intervention is commonly...

2013-06-27 23:18:21

High growth in smaller segments of the European interventional cardiology market contributes to continued increase and development of the total market. Vancouver, BC (PRWEB) June 27, 2013 Heart disease is a major cause of death and hospitalization in several European countries, as observed in a 2012 OECD (Organisation for Economic Co-Operation and Development) study. While previous methods for treating obstructed coronary arteries involved open-chest surgery, this is no longer the case...

2013-06-11 11:22:38

Study Highlights: -Opening clogged heart arteries via the radial artery in the wrist is becoming more common. -The wrist route may have fewer complications than the traditional route through the femoral artery in the groin. -Use of the procedure increased 13-fold in a six-year period. The way to a man´s heart may be his wrist. More U.S. doctors are unclogging heart arteries (in men and women) by entering through the radial artery in the wrist, which is linked to less bleeding...

2013-05-23 08:26:36

Company to Host Conference Call Today at 8:00am ET, 2:00pm CET PARIS, May 23, 2013 /PRNewswire/ -- InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today announced new 6-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard Embolic Protection Stent (EPS) outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation myocardial...

2013-05-23 04:21:45

Prospective, Multi-Center, Double-Blinded Study Confirms Prior Results in evaluating Volcano's iFR® (Instant Wave-Free Ratio(TM)) Software Modality in a Large, Real-World Population SAN DIEGO and PARIS, May 23, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary results from the ADVISE...

2013-05-21 08:28:47

- XIENCE Xpedition(TM) 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents ABBOTT PARK, Ill., May 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced CE Mark in Europe for the XIENCE Xpedition(TM) 48 Everolimus Eluting Coronary Stent System, the first-of-its-kind treatment for very long blockages in the vessels that supply blood to the heart due to coronary artery disease (CAD). XIENCE Xpedition 48 leverages the proven design and...


Latest Percutaneous coronary intervention Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »